Bottle top filter ideal for the filtration and sterilization of cell culture media, serum, and supplements.
The "VacuCap Filtration Sterilization Bottle Top Filter" is a revolutionary bottle top filter designed for rapid filtration sterilization of aqueous solutions ranging from 100 mL to 5 L and for the removal of mycoplasma. This filter minimizes plastic waste and is environmentally friendly, compatible with various collection containers, and helps reduce storage space and waste volume. 【Features】 - High flow rate achieved using Supor membrane - Removal of mycoplasma with a pore size of 0.1 μm - Filtration sterilization of culture media and supplements with a pore size of 0.2 µm - No need for additional injection into the upper liquid reservoir; direct suction from mixing containers is possible - Direct filtration into storage containers reduces contamination risk - Used as pre-filtration for exosome purification to remove microvesicles (0.1 µm, 0.2 µm) As an example of application, the 0.1 µm VacuCap is used for the clarification of supernatant from the culture of NIH3T3, a mouse embryonic fibroblast, as a preliminary step for concentrating and purifying exosomes. [1] Ji, H. et al., Electrophoresis. 29. 2660-2671
Inquire About This Product
basic information
【Other Features】 - Offers two sizes of filters that can be selected based on sample volume - Environmentally friendly filters that minimize plastic waste - Patent-pending compact design that accommodates various collection containers while reducing storage space and waste volume *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Application】 ■ Filtration sterilization of cell culture media and reduction of mycoplasma ■ Clarification of samples of several hundred mL ■ Utilized for the removal of microvesicles as pre-filtration for exosome purification (0.1 µm, 0.2 µm) *For more details, please refer to the PDF document or feel free to contact us.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.
